Awarded contract
Pharmaceutical products
Details
- Supplier(s)
- Alexion Pharmaceuticals
- Value
- GBP 300,000
- Topic
- Pharmaceutical products
- Published
- 23 October 2017
- Source
- TedNotices
Tender description
Branded patent protected medicines, Eculizummab 300 mg in 30 ml concentrate for iv infusion. Supply of branded patent protected medicines, Eculizummab 300 mg in 30 ml concentrate for iv infusion.
Timeline
- Completed: Award date5 May 2017
- Completed: Award published23 October 2017Current notice
About the buyer
Belfast Health and Social Care Trust is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@belfast-health-and-social-care-trust.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@belfast-health-and-social-care-trust.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@belfast-health-and-social-care-trust.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@belfast-health-and-social-care-trust.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@belfast-health-and-social-care-trust.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@belfast-health-and-social-care-trust.gov |
6 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to Belfast Health and Social Care Trust.
BuyersCountValue
- 87£530.0m
- 18£169.3m
- 12£24.3m
- 3£4.4m
- 514£239.2m
- 382£5.3bn
- 321£279.9m
- 262£44.9m
- 250£142.1m
- 231£25.7m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
